zelboraf (▼) 240 mg/1 tableta film tableta
roche d.o.o.roche ltd. - vemurafenib - film tableta - 240 mg/1 tableta - 1 film tableta sadrži: 240 mg vemurafenib
ranitidin replek farm 150 mg/1 tableta film tableta
unifarm d.o.o. lukavac - ranitidin - film tableta - 150 mg/1 tableta - 1 film tableta sadrži: 150 mg ranitidina (u obliku ranitidin hidrohlorida)
eritromicin farmavita 250 mg/1 kapsula kapsula, tvrda
farmavita d.o.o. sarajevo - eritromicin - kapsula, tvrda - 250 mg/1 kapsula - 1 kapsula, tvrda sadrži: 250 mg eritromicin (u obliku eritromicinestolata)
ranital 50 mg/5 ml rastvor za injekciju
novartis ba d.o.o. - ranitidin - rastvor za injekciju - 50 mg/5 ml - 1 ampula sa 5 ml rastvora za injekciju sadrži: 56 mg ranitidin hidrohlorida (što odgovara 50 mg ranitidina)
eritromicin farmavita 250 mg/1 kapsula kapsula, tvrda
farmavita d.o.o. sarajevo - eritromicin - kapsula, tvrda - 250 mg/1 kapsula - 1 kapsula, tvrda sadrži: 250 mg eritromicina (u obliku eritromicinestolata)
zelboraf 240 mg/1 tableta film tableta
roche d.o.o.roche ltd. - vemurafenib - film tableta - 240 mg/1 tableta - 1 film tableta sadrži: 240 mg vemurafeniba
phemiton 200 mg tablete
pliva hrvatska d.o.o., prilaz baruna filipovića 25, zagreb, hrvatska - metilfenobarbital - tableta - 200 mg - urbroj: svaka tableta sadrži 200 mg metilfenobarbitala
gastrobel 150 mg šumeće tablete
belupo lijekovi i kozmetika d.d., ulica danica 5, koprivnica - ranitidinum - šumeća tableta - 150 mg - urbroj: jedna šumeća tableta sadrži 150 mg ranitidina u obliku ranitidinklorida
tagrisso
astrazeneca ab - osimertinib mesilate - karcinom, ne-malih stanica pluća - drugi antitumorski lijekovi, inhibitori протеинкиназы - tagrisso as monotherapy is indicated for:- the adjuvant treatment after complete tumour resection in adult patients with stage ib-iiia non-small cell lung cancer (nsclc) whose tumours have epidermal growth factor receptor (egfr) exon 19 deletions or exon 21 (l858r) substitution mutations- the first-line treatment of adult patients nsclc with activating egfr mutations. - the treatment of adult patients with locally advanced or metastatic egfr t790m mutation-positive nsclc. tagrisso as monotherapy is indicated for:- the adjuvant treatment after complete tumour resection in adult patients with stage ib-iiia non-small cell lung cancer (nsclc) whose tumours have epidermal growth factor receptor (egfr) exon 19 deletions or exon 21 (l858r) substitution mutations. - the first-line treatment of adult patients with locally advanced or metastatic nsclc with activating egfr mutations. - the treatment of adult patients with locally advanced or metastatic egfr t790m mutation-positive nsclc.
martefarin 3 mg tablete
orion corporation, orionintie 1, espoo, finska - varfarinnatrij - tableta - 3 mg - urbroj: jedna tableta sadrži 3 mg varfarinnatrija